Eyenovia
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Eyenovia and buy or sell other stocks, ETFs, and their options commission-free!About EYEN
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes.
CEOMichael M. Rowe
CEOMichael M. Rowe
Employees14
Employees14
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2014
Founded2014
Employees14
Employees14
EYEN Key Statistics
Market cap4.78M
Market cap4.78M
Price-Earnings ratio-0.32
Price-Earnings ratio-0.32
Dividend yield—
Dividend yield—
Average volume8.57M
Average volume8.57M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$124.80
52 Week high$124.80
52 Week low$0.85
52 Week low$0.85
People also own
Based on the portfolios of people who own EYEN. This list is generated using Robinhood data, and it’s not a recommendation.